Skip to content
ppharmaranks
Menu
Class IIOngoing

Xylocaine (lidocaine HCl Injection recall

FDA recall D-0729-2026 · initiated Jul 16, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jul 29, 2026How we research

Fresenius Kabi USA, LLC recalled Xylocaine (lidocaine HCl Injection in Jul 2026 — an FDA Class II recall (D-0729-2026) because Presence of Particulate Matter: Hair was found in products.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Particulate Matter: Hair was found in products

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: 6133986, Exp. Date 02/2029

Quantity recalled: 37,250 vials

Details

Product
Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-57; NDC Vial: 63323-485-03
Recalling company
Fresenius Kabi USA LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide within in the USA
Initiated
Jul 16, 2026
FDA report date
Jul 29, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Xylocaine (lidocaine HCl Injection recalled?
Fresenius Kabi USA, LLC recalled Xylocaine (lidocaine HCl Injection in Jul 2026 — an FDA Class II recall (D-0729-2026) because Presence of Particulate Matter: Hair was found in products. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Xylocaine (lidocaine HCl Injection recalled?
Per the FDA enforcement record, the reason for recall D-0729-2026 was: Presence of Particulate Matter: Hair was found in products
Is a recalled Xylocaine (lidocaine HCl Injection dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Xylocaine (lidocaine HCl Injection are affected?
Distributed: Nationwide within in the USA. The recall covers these lots — Lot #: 6133986, Exp. Date 02/2029. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0729-2026.

Source: openFDA Drug Enforcement record D-0729-2026

← All drug recalls